Clinical Trials · NCT02682381

Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition

CompletedPhase 3Teduglutide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Shire
Enrollment
59
Start date
Jun 2016
Locations
27 sites, 7 countries
Primary endpoint
Number of Participants Who Achieved at Least a 20 Percent (%) Reduction in Weight-Normalized Average Daily Parenteral Nutrition Intravenous (PN/IV) Volume at Week 24
View Teduglutide compound reference